Companies: 10,795·Total market cap: $144.5T
Alto Neuroscience, Inc.

Alto Neuroscience, Inc.

ANRONYSEHealthcare● Active
$18.16
$-0.10(-0.55%)
Market Cap$637305950
P/E Ratio
52W High$28.441
52W Low$2.15
Overview

Alto Neuroscience, Inc. (ANRO) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · ANRO · as of Mar 16, 2026

Latest filing snapshot

68
-8-10.53%vs prior year

Alto Neuroscience, Inc. (ANRO) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing

SEC 10-K·Period end: 2025-12-31·Full-time · Global
Total Employees
68
Change (1Y)
-8
Growth % (1Y)
-10.53%
Revenue / Employee
Net Income / Employee
$-930.0K
Market Cap
$635M

ANRO Employee Count

2023 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing DateEmployeesChange (1Y)Growth (1Y)SEC filing link
2026-03-1668-8-10.53%
2025-03-2076+13+20.63%
2024-03-2163

Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology
#SymbolCompanyEmployees
#1
Amarin Corporation plc
AMRN
Amarin Corporation plc
275
#2
Cellectis S.A.
CLLS
Cellectis S.A.
216
#3
AC Immune S.A.
ACIU
AC Immune S.A.
133
#4
DBV Technologies S.A.
DBVT
DBV Technologies S.A.
106
#5
Alto Neuroscience, Inc.
ANRO
Alto Neuroscience, Inc.YOU
68
#6
Contineum Therapeutics, Inc. Class A Common Stock
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
41
#7
Aldeyra Therapeutics, Inc.
ALDX
Aldeyra Therapeutics, Inc.
9
Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · ANRO peer comparison

About ANRO employees

ANRO Employees · Headcount

Alto Neuroscience, Inc. (ANRO) employee data is sourced from the annual SEC 10-K filing. As of 2025, Alto Neuroscience, Inc. had 68 full-time employees globally. Full-time employees only. Global consolidated headcount.

Alto Neuroscience, Inc.'s workforce decreased by 8 (10.53%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

Frequently Asked Questions

ANRO Employees · 5 questions

As of the latest SEC 10-K filing (2025), Alto Neuroscience, Inc. had 68 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

Alto Neuroscience, Inc. employee counthow many employees does Alto Neuroscience, Inc. haveANRO total employees 2025

Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-16